StockNews.AI
ISPR
StockNews.AI
162 days

Ispire Technology Inc. to Participate in the 37th Annual ROTH Conference on March 16-18, 2025

1. Ispire participates in the 37th Annual ROTH Conference on March 16-18, 2025. 2. Co-CEO Michael Wang will chat live on March 18, 2025. 3. Management will engage with institutional investors during the conference. 4. Ispire owns or licenses over 200 patents globally. 5. The company is expanding its cannabis marketing efforts in Canada and Europe.

6m saved
Insight
Article

FAQ

Why Bullish?

Participation in a major conference and discussions with investors could enhance visibility and investor confidence. Historically, similar company engagements have led to positive stock performance.

How important is it?

The announcement of investor meetings and patent ownership indicates strong business potential, potentially affecting stock price significantly. The relevance stems from its participation in investor-focused events which can propel market interest.

Why Short Term?

The outcomes from the conference could lead to immediate shifts in investor perception. Previous conferences have shown strong short-term stock movements driven by investor sentiment.

Related Companies

CANVVAPOHWTCRON
LOS ANGELES, March 10, 2025 /PRNewswire/ --  Ispire Technology Inc. (NASDAQ: ISPR) ("Ispire," the "Company," "we," "us," or "our"), an innovator in vaping technology and precision dosing, today announced its participation in the 37th Annual ROTH Conference to be held on March 16-18, 2025 in Dana Point, California. Ispire's Co-CEO, Michael Wang, will participate in a fireside chat on Tuesday, March 18, 2025, at 1:00pm PST / 4:00pm EST. A live webcast of their discussion will be available to view here. Additionally, management will hold 1x1 meetings with institutional investors during the conference. For more information or to schedule a meeting with management, please contact ROTH MKM or email [email protected]. About Ispire Technology Inc.Ispire is engaged in the research and development, design, commercialization, sales, marketing, and distribution of branded e-cigarettes and cannabis vaping products. The Company's operating subsidiaries own or license more than 200 patents received or filed globally. Ispire's tobacco products are marketed under the Aspire brand name and are sold worldwide (except in the U.S., People's Republic of China and Russia) primarily through its global distribution network. The Company's cannabis products are marketed under the Ispire brand name primarily on an original design manufacturer (ODM) basis to other cannabis vapor companies. Ispire sells its cannabis vaping hardware only in the U.S., and it recently commenced its marketing activities in Canada and Europe. For more information, visit www.ispiretechnology.com or follow Ispire on  Instagram, LinkedIn, Twitter and YouTube. Any information contained on, or that can be accessed through, the Company's website, any other website or any social media, is not a part of this press release. Forward Looking Statements This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended ("Securities Act") as well as Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, as amended, that are intended to be covered by the safe harbor created by those sections. Forward-looking statements, which are based on certain assumptions and describe the Company's future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as "believe," "expect," "may," "will," "should," "would," "could," "seek," "intend," "plan," "goal," "project," "estimate," "anticipate," "strategy," "future," "likely" or other comparable terms, although not all forward-looking statements contain these identifying words. All statements other than statements of historical facts included in this press release regarding the Company's strategies, prospects, financial condition, operations, costs, plans and objectives are forward-looking statements. Important factors that could cause the Company's actual results and financial condition to differ materially from those indicated in the forward-looking statements. Such forward-looking statements include, but are not limited to, risks and uncertainties including those regarding: the Company's ability to collect its accounts receivable in a timely manner, the Company's business strategies, the ability of the Company to market to the Ispire ONE™, Ispire ONE's success if meeting its goals, the ability of its customers to derive the anticipated benefits of the Ispire ONE™ and the success of their products on the markets; the Ispire ONE™ proving to be safe, and the risk and uncertainties described in "Risk Factors," "Management's Discussion and Analysis of Financial Condition and Results of Operations," "Cautionary Note on Forward-Looking Statements" and the additional risk described in Ispire's Annual Report on Form 10-K for the year ended June 30, 2024 and any subsequent filings which Ispire makes with the U.S. Securities and Exchange Commission. You should not rely upon forward-looking statements as predictions of future events. The forward-looking statements made in the press release relate only to events or information as of the date on which the statements are made in the press release. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events except as required by law. You should read this press release with the understanding that our actual future results may be materially different from what we expect. IR Contacts:For more information, kindly contact:Investor RelationsSherry Zheng718.213.7386[email protected] KCSA Strategic CommunicationsPhil Carlson212.896.1233[email protected] PR Contact:Ellen Mellody570.209.2947[email protected] SOURCE Ispire Technology Inc.

Related News